China Literature Limited (772) has announced approval of a plan to exercise a mandate granted by its shareholders on May 30, 2025, allowing the company to buy back up to 10% of its total issued ordinary shares. Under the approved framework, a maximum of 102,208,922 shares may be repurchased on the market, subject to compliance with Listing Rules and other applicable regulations.

The initiative, not exceeding HKD1.2 billion, is expected to last no more than 12 months. China Literature Limited intends to fund the buy-back from existing available cash reserves and free cash flow, with no external borrowing involved. The board of directors states that current resources allow for execution of the plan while maintaining sufficient resources for operational growth. The plan remains discretionary and contingent on market conditions, with no assurance of the timing, quantity, or price of any repurchases.